2016-02-05 08:01:09 CET

2016-02-05 08:01:09 CET


BIRTINGARSKYLDAR UPPLÝSNINGAR

Enska Finnska
Revenio Group Oyj - Total number of voting rights and capital

Revenio Group Corporation: Increased number of shares entered into trade register


Revenio Group Corporation, Stock Exchange Release, January 5, 2016 at 9:00

INCREASED NUMBER OF SHARES ENTERED INTO TRADE REGISTER

7,500 new share subscriptions based on the company's 2007C stock options
approved by the Board of Directors of Revenio Group Corporation on December
16, 2015, have been entered into the trade register today. The share
subscription price under 2007C option rights was 1.24 EUR per share. The
subscription period for 2007C options is to May 1, 2016.

After these subscriptions, the number of Revenio Group Corporation's shares and
votes will rise to 7,953,928. These increases were recorded in their entirety in
the unrestricted shareholders' equity fund.

Revenio Group Corporation has applied for the listing of its new shares on the
Nasdaq Helsinki in the same series as the company's existing shares. According
to the current estimate, the new shares will be listed on January 8, 2016.

Revenio Group Oyj
Olli-Pekka Salovaara
CEO


For further information, please contact:

President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520
olli-pekka.salovaara@revenio.fi
www.revenio.fi

DISTRIBUTION:
NASDAQ Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi


The Revenio Group in brief

Revenio is a Finnish health tech group whose core business is in tonometers. The
Revenio Health Tech segment comprises the business operations of Icare Finland
Oy, Revenio Research Oy and Oscare Medical Oy, which specializes in osteoporosis
screening and monitoring. In addition, Revenio has identified new growth
opportunities relating to health tech in which common denominators are
screening, follow-up and the global need to make cost savings in health care via
preventive measures. Revenio seeks vigorous growth in health technology, both
organically and through acquisitions and mergers.

In 2014, the Revenio Group's net sales totaled MEUR 16.0, with its operating
profit (EBIT) from continuing operations standing at 27.5%. The Revenio Group
Corporation is listed on NASDAQ OMX Helsinki.


[HUG#1983998]